Hormone replacement therapy and breast density changes (Q30437754)

21 June 2017

Hormone replacement therapy and breast density changes (English)

1 reference

Hormone Replacement Therapy

21 June 2017

1 reference

J Harvey

1

1 reference

21 June 2017

C Scheurer

2

1 reference

21 June 2017

F T Kawakami

3

1 reference

21 June 2017

E Quebe-Fehling

4

1 reference

21 June 2017

P Ibarra de Palacios

5

1 reference

21 June 2017

V V Ragavan

6

1 reference

21 June 2017

1 June 2005

1 reference

21 June 2017

1 reference

21 June 2017

8

1 reference

21 June 2017

2

1 reference

21 June 2017

185-192

1 reference

Hormonal replacement therapy: mammographic manifestations

21 June 2017

1 reference

https://api.crossref.org/works/10.1080%2F13697130500103458

Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500103458

Mammographic density changes during different postmenopausal hormone replacement therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500103458

Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500103458

Use and cost of breast imaging for postmenopausal women undergoing hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500103458

Mammographic features and breast cancer risk: effects with time, age, and menopause status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500103458

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500103458

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500103458

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500103458

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500103458

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500103458

The Million Women Study and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500103458

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130500103458

10.1080/13697130500103458

21 January 2018

Identifiers

DOI

1 reference

21 June 2017

1 reference